Pentixapharm Holding AG (XTER:PTP) Change In Inventory : €0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Pentixapharm Holding AG Change In Inventory?

Pentixapharm Holding AG's change in inventory for the quarter that ended in Jun. 2024 was €0.00 Mil. It means Pentixapharm Holding AG's inventory stayed the same from Dec. 2023 to Jun. 2024 .

Pentixapharm Holding AG's change in inventory for the fiscal year that ended in Dec. 2023 was €0.00 Mil. It means Pentixapharm Holding AG's inventory stayed the same from Dec. 2022 to Dec. 2023 .

Pentixapharm Holding AG's Total Inventories for the quarter that ended in Jun. 2024 was €0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Pentixapharm Holding AG's Inventory-to-Revenue for the quarter that ended in Jun. 2024 was 0.00.

Pentixapharm Holding AG Change In Inventory Historical Data

The historical data trend for Pentixapharm Holding AG's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pentixapharm Holding AG Change In Inventory Chart

Pentixapharm Holding AG Annual Data

Trend

Dec21

Dec22

Dec23

Change In Inventory

Pentixapharm Holding AG Semi-Annual Data
	Dec21	Dec22	Jun23	Dec23	Jun24
Change In Inventory	-	-	-	-	-

Pentixapharm Holding AG Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Pentixapharm Holding AG (XTER:PTP) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Pentixapharm Holding AG's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	-1.204	*	365 / 2
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Pentixapharm Holding AG's Inventory Turnover for the quarter that ended in Jun. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	-1.204	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Pentixapharm Holding AG's Inventory to Revenue for the quarter that ended in Jun. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0.089
	=	0.00

Pentixapharm Holding AG Change In Inventory Related Terms

Thank you for viewing the detailed overview of Pentixapharm Holding AG's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Pentixapharm Holding AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pentixapharm Holding AG (XTER:PTP) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

PTPN:Austria

Address

Robert-Rossle-Street 10, Berlin, DEU

Website

https://www.pentixapharm.com

Pentixapharm Holding AG is a clinical-stage biopharmaceutical company active in the field of research and development of radiopharmaceuticals for diagnostic and therapeutic applications. Radiopharmaceuticals are medical substances containing radioactive elements used in nuclear medicine to diagnose or treat diseases. Its clinical pipeline encompasses PentixaTher, a Yttrium-90 based therapeutic against non-Hodgkin lymphomas (NHL), and PentixaFor, a Gallium-68-based companion diagnostic.

Pentixapharm Holding AG Headlines

No Headlines